EP Wealth Advisors LLC raised its holdings in The Procter & Gamble Company (NYSE:PG – Free Report) by 5.3% in the third quarter, Holdings Channel reports. The fund owned 103,424 shares of the company’s stock after acquiring an additional 5,177 shares during the period. EP Wealth Advisors LLC’s holdings in Procter & Gamble were worth $17,913,000 at the end of the most recent quarter.
A number of other hedge funds also recently modified their holdings of the business. Itau Unibanco Holding S.A. bought a new position in shares of Procter & Gamble during the second quarter worth about $28,000. Fairway Wealth LLC acquired a new position in shares of Procter & Gamble during the 2nd quarter worth about $29,000. RPg Family Wealth Advisory LLC bought a new position in shares of Procter & Gamble in the 3rd quarter valued at about $33,000. POM Investment Strategies LLC bought a new stake in Procter & Gamble during the second quarter worth about $34,000. Finally, Quest Partners LLC bought a new position in Procter & Gamble in the second quarter valued at approximately $36,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Stock Performance
Shares of Procter & Gamble stock opened at $173.83 on Friday. The company has a market cap of $409.38 billion, a P/E ratio of 29.97, a PEG ratio of 3.77 and a beta of 0.44. The business has a 50-day moving average price of $170.75 and a two-hundred day moving average price of $169.34. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $180.43.
Procter & Gamble Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.32%. Procter & Gamble’s payout ratio is 69.48%.
Insider Activity at Procter & Gamble
In related news, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the sale, the chief executive officer now directly owns 39,977 shares in the company, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the sale, the insider now directly owns 11,566 shares in the company, valued at approximately $1,954,538.34. This trade represents a 52.53 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 83,080 shares of company stock valued at $14,629,038 over the last ninety days. Corporate insiders own 0.18% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on the stock. Wells Fargo & Company upped their target price on shares of Procter & Gamble from $188.00 to $190.00 and gave the company an “overweight” rating in a report on Friday, November 22nd. Piper Sandler started coverage on Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price on the stock. Morgan Stanley raised their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday, October 21st. Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a report on Monday, September 30th. Finally, Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $180.45.
Read Our Latest Analysis on Procter & Gamble
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Basic Materials Stocks Investing
- Nebius Group Stock: A Rising AI Infrastructure Star
- Where Do I Find 52-Week Highs and Lows?
- Celsius Stock May Thrive as Pepsi and Coca-Cola Face Headwinds
- Stock Market Upgrades: What Are They?
- Lemonade’s AI Edge: A Disruptor in the Insurance Industry
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.